Novel 4-thiazolidinone derivatives as agonists of benzodiazepine receptors
Loading...
Date
2017-01-13
Authors
Faizi, Mehrdad
Jahani, Reza
Ebadi, Seyed Abbas
Tabatabai, Sayyed Abbas
Rezaee, Elham
Lotfaliei, Mehrnaz
Amini, Mohsen
Almasirad, Ali
Journal Title
Journal ISSN
Volume Title
Publisher
Alternative Title(s)
Design, synthesis and pharmacological evaluation
Abstract
A new series of 4-chloro-N-(2-(substitutedphenyl)-4-oxothiazolidin-3-yl)-2-phenoxybenzamide derivatives were designed, synthesized and biologically evaluated as anticonvulsant agents. The designed compounds have the main essential functional groups for binding to the benzodiazepine receptors and 4-thiazolidinone ring as an anticonvulsant pharmacophore. Some of the new synthesized compounds showed considerable anticonvulsant activity in electroshock and pentylenetetrazole-induced lethal convulsion tests. Compound 5i, 4-chloro-N-(2-(4-methoxyphenyl)-4-oxothiazolidin-3-yl)-2-phenoxybenzamide, with the best activity was selected for evaluation of other benzodiazepine pharmacological effects. This compound induced significant sedative-hypnotic activity. However, it does not impair the learning and memory in the experimental condition. Flumazenil was able to antagonize the sedative-hypnotic and anticonvulsant effects of compound 5i indicating that benzodiazepine receptors are highly involved in the pharmacological properties of the novel compounds.
Description
Table of contents
Keywords
benzodiazepine, sedative-hypnotic, anticonvulsant, 4-thiazolidinone derivatives, synthesis